Westfield Capital Management Company »

Moonlake Immunot shares owned by Westfield Capital Management Company

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Westfield Capital Management Company from 13F filings

Historical chart of Westfield Capital Management Company investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Westfield Capital Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Westfield Capital Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $37M 612k 60.39
2023-09-30 $22M 391k 57.00
2023-06-30 $21M 410k 51.00

More positions owned by Westfield Capital Management Company

Microsoft Corporation (MSFT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
NVIDIA Corporation (NVDA)
Visa Com Cl A (V)
Meta Platforms Cl A (META)
Builders FirstSource (BLDR)
Dex (DXCM)
UnitedHealth (UNH)
Servicenow (NOW)
Axon Enterprise (AXON)
Saia (SAIA)

View all positions for Westfield Capital Management Company

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot